Delivery Order SPE2DB22D3019-SPE2DB26FK2SZ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,709.98 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages). This firm fixed-price delivery order, awarded on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a competitively awarded non-set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,873.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,606.18 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract. The award, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,721.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,883.17 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $56,815.09 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed price contract. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,578.75 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,715.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract was awarded on April 28, 2025, with an ultimate completion date of April 29, 2025, using firm fixed-price pricing with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB26FK2SZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,949.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor under the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. This delivery order for Jardiance, a diabetes management medication, exemplifies the company's role in supplying essential brand-name pharmaceuticals to federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 10/27/25 |